⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15682915 | 0.79 | — | — | |
| SCHEMBL22801231 | 0.74 | — | — | |
| SCHEMBL14064163 | 0.72 | — | — | |
| SCHEMBL15557296 | 0.71 | — | — | |
| SCHEMBL7572703 | 0.70 | LMNA (0.30) | — | |
| SCHEMBL10138045 | 0.65 | — | — | |
| SCHEMBL24945919 | 0.65 | — | — | |
| SCHEMBL6439415 | 0.65 | — | — | |
| SCHEMBL20343302 | 0.65 | — | — | |
| SCHEMBL13801800 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112979695-B | Method for preparing 1, 2-di-fatty acyl-sn-glycerol-3-phosphatidylserine | 苏州昊帆生物股份有限公司 | 2022-04-12 | — | — | CN | claimed |
| US-10414790-B2 | Exocyclic nitrogen atom protected nucleoside and method for producing and using the same | THE REGENTS OF THE UNIVERSITY OF COLORADO (US) | 2019-09-17 | — | — | US | claimed |
| US-20150225442-A1 | EXOCYLIC NITROGEN ATOM PROTECTED NUCLEOSIDE AND METHOD FOR PRODUCING AND USING THE SAME | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2015-08-13 | — | — | US | claimed |
| WO-2014022839-A1 | EXOCYLIC NITROGEN ATOM PROTECTED NUCLOSIDE AND METHOD FOR PRODUCING AND USING THE SAME | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2014-02-06 | — | — | WO | claimed |
| WO-2025063239-A1 | SIRNA CAPABLE OF SUPPRESSING EXPRESSION OF α-SYNUCLEIN | 第一三共株式会社 | 2025-03-27 | — | — | WO | disclosed |
| WO-2025063238-A1 | SIRNA FOR SUPPRESSING EXPRESSION OF PHOSPHOLAMBAN | 第一三共株式会社 | 2025-03-27 | — | — | WO | disclosed |
| CN-112979695-B | Method for preparing 1, 2-di-fatty acyl-sn-glycerol-3-phosphatidylserine | 苏州昊帆生物股份有限公司 | 2022-04-12 | — | — | CN | disclosed |
| CN-112979695-B | Method for preparing 1, 2-di-fatty acyl-sn-glycerol-3-phosphatidylserine | 苏州昊帆生物股份有限公司 | 2022-04-12 | — | — | CN | disclosed |
| US-10414790-B2 | Exocyclic nitrogen atom protected nucleoside and method for producing and using the same | THE REGENTS OF THE UNIVERSITY OF COLORADO (US) | 2019-09-17 | — | — | US | disclosed |
| US-20150225442-A1 | EXOCYLIC NITROGEN ATOM PROTECTED NUCLEOSIDE AND METHOD FOR PRODUCING AND USING THE SAME | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2015-08-13 | — | — | US | disclosed |
| US-8957201-B2 | Oligonucleotide analogues and methods utilizing the same | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2015-02-17 | — | — | US | disclosed |
| WO-2014022839-A1 | EXOCYLIC NITROGEN ATOM PROTECTED NUCLOSIDE AND METHOD FOR PRODUCING AND USING THE SAME | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2014-02-06 | — | — | WO | disclosed |
| US-20090149404-A1 | Oligonucleotide analogues and methods utilizing the same | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2009-06-11 | — | — | US | disclosed |
| US-7335765-B2 | Nucleoside and oligonucleotide analogues | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2008-02-26 | — | — | US | disclosed |
| US-7314923-B2 | Nucleoside and oligonucleotide analogues | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2008-01-01 | — | — | US | disclosed |
| US-20050261235-A1 | 2' ,5' -Oligoadenylate analogs | SANKYO COMPANY, LIMITED (JP) | 2005-11-24 | — | — | US | disclosed |
| EP-1568704-A1 | NOVEL 2' ,5' -OLIGOADENYLIC ACID ANALOGUES | Sankyo Company, Limited (JP) | 2005-08-31 | — | — | EP | disclosed |
| US-20030207841-A1 | Novel nucleoside and oligonucleotide analogues | SANKYO COMPANY LIMITED (JP) | 2003-11-06 | — | — | US | disclosed |
| US-20020147332-A1 | Novel nucleoside and oligonucleotide analogues | SANKYO COMPANY, LIMITED (JP) | 2002-10-10 | — | — | US | disclosed |
| EP-1152009-A1 | NOVEL NUCLEOSIDES AND OLIGONUCLEOTIDE ANALOGUES | Sankyo Company, Limited (JP) | 2001-11-07 | — | — | EP | disclosed |